ClinConnect ClinConnect Logo
Search / Trial NCT06187012

Hypertension Explored in Long-term Postpartum Follow-up in Later Life

Launched by UNIVERSITY OF OXFORD · Dec 15, 2023

Trial Information

Current as of November 08, 2025

Recruiting

Keywords

Hypertensive Pregnancy Older Adults Pre Eclampsia Gestational Hypertension Cardiovascular Risk Disease Progression Longitudinal

ClinConnect Summary

This clinical trial is looking to understand why women who have experienced high blood pressure during pregnancy might be more likely to develop high blood pressure and heart problems later in life. The study is specifically aimed at women who had a pregnancy between 10 to 25 years ago and want to learn more about their long-term health.

To participate, women need to be willing to give their consent and be able to understand the study details in English. It's important to note that pregnant women (more than 10 weeks along) or those with certain heart or serious chronic diseases cannot join the study. If eligible, participants can expect to share their health information and possibly undergo tests to help researchers gather valuable insights about heart and blood vessel health in women after pregnancy.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion Criteria
  • Participant is willing and able to give informed consent for participation in the study
  • Female who had a pregnancy 10 to 25 years prior
  • Able (in the investigator's opinion) and willing to comply with all study requirements.
  • Adequate understanding of verbal and written English
  • Exclusion Criteria:
  • * The participant may not enter the study if ANY of the following apply:
  • Over 10 weeks pregnant during the course of the study
  • Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
  • Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
  • For exclusion of MRI component only:
  • • Unsuitable for MRI based on the responses to the MRI screening form. The participant may still be included in other parts of the study.

About University Of Oxford

The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.

Locations

Oxford, United Kingdom

Patients applied

0 patients applied

Trial Officials

Paul Leeson

Principal Investigator

University of Oxford

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported